| Systematic (IUPAC) name | |
|---|---|
| (2R)-2-[(2R,3S,5S,6R)-6-[(1S,2S,3S,5R)-5- [(2S,5S,7R,9S,10S,12R,15R)-2-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyl-2-tetrahydropyranyl]-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl]-2-hydroxy-1,3-dimethyl-4-oxoheptyl]-3,5-dimethyl-2-tetrahydropyranyl]butanoic acid | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 55134-13-9 |
| ATCvet code | QP51AH04 |
| PubChem | CID 65452 |
| UNII | DZY9VU539P |
| Synonyms | (4S)-4-methyl-salinomycin |
| Chemical data | |
| Formula | C43H72O11 |
| Mol. mass | 765.03 g/mol |
| SMILES | eMolecules & PubChem |
| (what is this?) (verify) |
|
Narasin is a coccidiostat and antibacterial agent. It is a derivative of salinomycin which has an additional methyl group.